healthDaraxonrasib combination shrinks tumours in pancreatic cancer trialA daily daraxonrasib pill combined with chemotherapy was associated with tumour shrinkage or disappearance in 60.7% of 61 patients with advanced pancreatic cancer, according to trial results presented in Barcelona.... Coverage Mix 9 source articles Left 11% Centre 33% Right 56% 8 hours agohealth